CX Institutional Purchases 196 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

CX Institutional grew its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1.6% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 12,196 shares of the exchange traded fund’s stock after buying an additional 196 shares during the quarter. CX Institutional’s holdings in SPDR S&P Biotech ETF were worth $1,098,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of XBI. Hartline Investment Corp grew its position in SPDR S&P Biotech ETF by 2.0% during the 3rd quarter. Hartline Investment Corp now owns 5,502 shares of the exchange traded fund’s stock worth $544,000 after acquiring an additional 106 shares during the last quarter. Signature Estate & Investment Advisors LLC grew its holdings in shares of SPDR S&P Biotech ETF by 5.7% during the third quarter. Signature Estate & Investment Advisors LLC now owns 2,336 shares of the exchange traded fund’s stock worth $231,000 after purchasing an additional 125 shares during the last quarter. Denver Wealth Management Inc. grew its holdings in shares of SPDR S&P Biotech ETF by 0.9% during the third quarter. Denver Wealth Management Inc. now owns 14,779 shares of the exchange traded fund’s stock worth $1,460,000 after purchasing an additional 127 shares during the last quarter. Trust Co. of Vermont increased its stake in shares of SPDR S&P Biotech ETF by 4.7% in the third quarter. Trust Co. of Vermont now owns 3,058 shares of the exchange traded fund’s stock valued at $302,000 after buying an additional 138 shares in the last quarter. Finally, Graypoint LLC raised its holdings in shares of SPDR S&P Biotech ETF by 5.6% in the third quarter. Graypoint LLC now owns 2,738 shares of the exchange traded fund’s stock valued at $271,000 after buying an additional 146 shares during the last quarter.

SPDR S&P Biotech ETF Stock Down 0.6 %

Shares of NYSEARCA:XBI opened at $92.46 on Friday. The firm has a market cap of $7.05 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47. The company’s 50-day moving average price is $93.34 and its two-hundred day moving average price is $96.88.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.